Roundup Fee Caps, Judge Rogers’ Depo-Provera Push, and Weight Loss Drug Timelines

Major hearings are underway across the largest mass tort dockets leading into MTMP! In this episode of Tort Talk, Jon Robinson, Marc Rioux, and Joe Fantini break down key developments in Roundup, Depo-Provera, GLP-1 Weight Loss drugs, and Hair Relaxer litigation. We dive deep into the recent $7.25B Roundup class action approval hearing in Missouri State Court, what Monsanto’s "take it or leave it" stance means for 60,000+ plaintiffs, and how attorney fee caps drop to 22–25% for newly signed unfiled cases. In Depo-Provera, we analyze Pfizer’s risky stance on remaining unsettled claims and why Judge Rogers is forcing aggressive Daubert hearings. Then, we compare the two distinct paths of GLP-1 weight loss litigation, gastroparesis versus NAION eye injuries, and provide a timeline for upcoming expert rulings. Finally, Joe Fantini gives his bold prediction on whether Hair Relaxer will reach a global settlement by the end of 2026. Timestamps: 00:00 - Introduction & Upcoming MTMP Preview 00:45 - Roundup: $7.25B Settlement Hearing, Objector Arguments & Fee Caps 05:43 - Depo-Provera: Pfizer’s Settlement Exclusions & Judge Rogers’ Daubert Strategy 10:50 - Weight Loss Litigation: Gastroparesis vs. NAION Schedules & Expert Battles 14:02 - Hair Relaxer: Preemptive Defense Strikes & End-of-Year Settlement Predictions 17:06 - Special Tease for Next Week's Episode & Wrap-Up #MassTorts #RoundupSettlement #HairRelaxer #DepoProvera #GLP1Litigation #Gastroparesis #LawFirmGrowth #TortTalk #MassTortsMadePerfect #LegalStrategy #PlaintiffLaw About The Jon & Marc Podcast The Jon & Marc Podcast is for lawyers who care about growth and the bottom line. Jon and Marc interview leaders in plaintiff law to break down how major cases are built, how firms scale, and how strategy plays out behind the scenes. If you want to understand how the biggest players in the space think and operate, you’re in the right place. New episodes every week.